Catalogue Number: 361563-USB
| Manufacturer: | United States Biological |
| Physical state: | Supplied as a liquid in PBS, pH 7.2, 0.02% Proclin-300. |
| Type: | Monoclonal Primary Antibody - Unconjugated |
| Alias: | CD154|CD40 antigen ligand|CD40 ligand|CD40L|CD40-L|gp39|hCD40L|HIGM1|IGM|IMD3|T-B cell-activating molecule|T-BAM|T-cell antigen Gp39|TNF-related activation protein|TNFSF5|TRAP|tumor necrosis factor (ligand) superfamily member 5 |
| Shipping Condition: | Blue Ice |
| Unit(s): | 200 ug |
| Host name: | Human |
| Clone: | hu5c8 (Ruplizumab) (recomb) |
| Isotype: | IgG1, kappa |
| Immunogen: | Human CD40L |
| Application: | FC, WB |
Description: Recombinant monoclonal antibody to CD40L with variable regions (i.e. specificity) from the original hybridoma hu5c8 (Ruplizumab). Manufactured using a proprietary recombinant platform technology. Not for therapeutic use; this is a research grade biosimilar. The antibody binds specifically to CD40L, a surface receptor expressed on activated T cells which acts as a costimulatory molecule to trigger immune responses. The antibody neutralises CD40L function, as it blocks the interaction between CD40 and CD40L. When injected into cynomolgus monkeys, the original therapeutic antibody was found to have a T1/2 of 531+/-155 hours.
P29965
CD40LG
959
Recognizes human CD40L. Binds to CD40L with an IC50 of 0.845ug/ml.
Protein A purified
Recombinant Monoclonal